The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1305-1312

  Kikuno, Nobuyuki ^a   Yoshino, Tateki ^a   Urakami, Shinji ^a   Shigeno, Kazushi ^a   Kishi, Hirofumi ^a   Hata, Kohkichi ^a   Shiina, Hiroaki ^a   Igawa, Mikio ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Color doppler ultrasonography; Microvessel density; Prostate cancer; Thymidine phosphorylase; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STROMA CELL;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; BLOOD FLOW VELOCITY; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LASER-DOPPLER FLOWMETRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STROMAL CELLS; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038577078     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Miyazono K, Okabe T, Urabe A et al: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098-4103, 1987.
3. Ishikawa F, Miyazono K, Hellman U et al: Identification of angiogenic activity and the cloning and expression of platelet - derived endothelial cell growth factor. Nature 338: 557-562, 1989.
4. Okada K, Yokoyama K, Okihara K et al: Immunohistochemical localization of platelet - derived endothelial cell growth factor expression and its relation to angiogenesis in prostate. Urology 57(2): 376-381, 2001.
5. Lavoipierre AM, Snow RM, Fryndenberg M et al: Prostatic cancer: role of color Doppler imaging in transrectal sonography. Am J Roentenol 171: 205-210, 1998.
6. Bree RL: The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49: 31-34, 1997.
7. Shigeno K, Igawa M, Shiina H, Wada H and Yoneda T: The role of colour doppler ultrasonography in detecting prostate cancer. BJU Int 86: 229-233, 2000.
8. Sobin LH and Wittekind Ch: TNM Classification of Malignant Tumors (5th ed), Wiley-Liss Inc., 1997.
9. Gleason DF: Histological grading of prosate cancer. A perspective. Hum Pathol 23: 273-279, 1992.
10. Hata K, Kamikawa T, Arao S et al: Expression of the thymidine phosphorylase gene in epithelial ovarian cancer. Br J Cancer 79: 1848-1854, 1999.
11. Arao S, Suwa H, Mandai M et al: Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res 54: 1355-1359, 1994.
12. Weidner N, Semple JP, Welch WR et al: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
13. Mizutani Y, Okada Y and Yoshida O: Expression of platelet - derived endothelial cell growth factor in bladder carcinoma. Cancer 79: 1190-1194, 1997.
14. Reynolds K, Farzaneh F, Collins WP et al: Association of ovarian malignancy with expression of platelet - derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238, 1994.
15. Gonzague DP, Thierry F, Marc Z et al: Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases. J Urol 166: 1924-1928, 2001.
16. Weidner N, Carroll PR, Flax J, Blumenfedl W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
17. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS and Germain MJ: Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 58: 1587-1590, 1977.
18. Campbell SC: Advances in angiogenesis research: relevance to urological oncology. J Urol 158: 1663-1674, 1997.
19. Joseph IB, Nelson JB, Denmeade SR and Isaacs JT: Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 3(12 Pt 1): 2507-2511, 1997.
20. Latil A, Bieche I, Pesche S, Valeri A, Fournier G, Cussenot O and Lidereau R: VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 89(2): 167-171, 2000.
21. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimot K, Akiba S, Miyadera K, Fukushima M, Yamada Y, Yoshida H, Kanzaki T and Akiyama S: The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. In press, 2003.